Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$93.64 +0.22 (+0.24%)
As of: Oct 2, 2026 · 2:18 PM EDT

Rhythm Pharmaceuticals (RYTM) Change in Account Payables (2016 - 2017)

Updated

Rhythm Pharmaceuticals' Change in Account Payables was -$105,000 in FY2017, compared with -$470,000 in FY2016.

Analysis

Rhythm Pharmaceuticals (RYTM) Change in Account Payables (2016 - 2017) Analysis & Trends

  • Per Business Quant data, Change in Account Payables in earlier years was -$470,000 in FY2016 and $575,000 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -70.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -66.70 Mn
10 Rhythm Pharmaceuticals 6.55 Bn 5.42 Bn 62.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 -105,000.00
Dec 31, 2016 -609,000.00
API Access

Rhythm Pharmaceuticals Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=RYTM&period=max&api_key=YOUR_API_KEY